Inactive Instrument

Calendar Inovio Pharmaceuticals Inc Nyse

Equities

US45773H1023

End-of-day quote Nyse
- USD - Intraday chart for Inovio Pharmaceuticals Inc

Chart calendar Inovio Pharmaceuticals Inc

db2aa39bfe34af7ab2d.0tf5yAwW_B_Uj4JqAj19k1pCtp6SL72CDtBipLs1_YA.hYeyhX0il1q2_vNcZ1kQ4jF35vH4bJDYQLQG3uJXvK2Xk6agZWCRaLzosg~9a0c8d1521b131d6042f7c2fdb673e46

Upcoming events on Inovio Pharmaceuticals Inc

14/05/2024 01:35 am Q1 2024 Earnings Release
14/05/2024 02:00 am Q1 2024 Earnings Call
14/05/2024 09:00 pm Citizens JMP Life Sciences Conference
15/05/2024 07:30 pm RBC Capital Markets Global Healthcare Conference
20/05/2024 10:00 pm H.C. Wainwright BioConnect Investor Conference
21/05/2024 06:30 pm Annual General Meeting
07/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
04/03/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Inovio Pharmaceuticals Inc

08/04/2024 02:00 am American Association for Cancer Research Meeting - Abstract No:1191
08/04/2024 02:00 am American Association for Cancer Research Meeting - Abstract No:976
02/04/2024 07:30 pm Citizens JMP Novel Therapeutics Forum
07/03/2024 03:00 am Q4 2023 Earnings Call
07/03/2024 02:35 am Q4 2023 Earnings Release
14/02/2024 11:10 pm Oppenheimer Healthcare Life Sciences Conference - Fireside Chat
25/01/2024 Reverse Split: 1 of 12
12/01/2024 09:30 pm Extraordinary Shareholders Meeting
10/11/2023 03:00 am Q3 2023 Earnings Call
10/11/2023 02:35 am Q3 2023 Earnings Release
13/09/2023 02:00 am H.C. Wainwright Global Investment Conference
10/08/2023 02:00 am Q2 2023 Earnings Call
10/08/2023 01:35 am Q2 2023 Earnings Release
09/06/2023 05:30 pm Jefferies Global Healthcare Conference - Fireside Chat
18/05/2023 01:35 am RBC Global Healthcare Conference
16/05/2023 06:30 pm Annual General Meeting
11/05/2023 02:00 am Q1 2023 Earnings Call
11/05/2023 01:35 am Q1 2023 Earnings Release
05/05/2023 06:30 pm American Broncho-Esophagological Association Combined Otolaryngology Spring Meeting
16/04/2023 12:00 pm European of Clinical Microbiology and Infectious Diseases Congress - Abstract No : MMK0202

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
4,11
5,11
-19.55%
7,41
3,84
93.02%
1,77
1,46
21.45%
10,3
10,6
-2.75%
0,83
1,07
-22.05%

0,60

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-298
-258
-15.56%
-263
-245
-7.61%
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-111
-104
-6.96%
-124
-131
5.51%
-301
-259
-16.14%
-268
-253
-5.71%
-144
-139
-3.2%

-110

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-121
-107
-13.32%
-163
-179
9.13%
-303
-259
-17.07%
-278
-263
-5.61%
-135
-137
1.22%

-102

Net income
Million USD
Released
Forecast
Spread
-119
-106
-12.49%
-166
-181
8.13%
-304
-261
-16.33%
-280
-264
-6.02%
-135
-137
1.55%

-99,4

EPS
USD
Released
Forecast
Spread
-14,5
-12,9
-12.48%
-12,8
-14,1
8.84%
-17,4
-15,2
-14.68%
-14,0
-13,3
-5.6%
-6,09
-5,11
-19.08%

-3,85

Announcement Date12/03/2001/03/2101/03/2201/03/2306/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,84
0,55
52.59%
0,20
0,66
-69.99%
0,78
0,52
50.65%
9,15
0,62
1368.96%
0,12
0,42
-70.6%
0,11
0,28
-58.2%
0,23
0,26
-13.92%
0,39
0,26
47.98%
0,10
0,34
-70.17%

0,15


0,15


0,15


0,15

EBITDA
Million USD
Released
Forecast
Spread
-104
-64,4
-62.28%



-103
-70,1
-47.05%
-34,7
-70,5
50.72%
-54,9
-37,3
-47.24%
























EBIT
Million USD
Released
Forecast
Spread
-106
-63,6
-65.93%
-71,7
-74,5
3.67%
-104
-67,0
-55.35%
-35,8
-70,1
49%
-55,9
-41,5
-34.92%
-44,0
-34,4
-27.66%
-37,0
-35,8
-3.61%
-35,6
-34,9
-1.82%
-27,4
-25,0
-9.5%

-27,6


-27,0


-27,8


-27,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-107
-63,1
-69.51%
-79,1
-74,7
-5.82%
-108
-67,3
-61.25%
-37,8
-70,4
46.36%
-54,5
-42,6
-27.9%
-40,6
-38,4
-5.85%
-35,5
-38,1
6.64%
-33,9
-34,3
1.19%
-25,0
-26,1
4.14%

-25,8


-25,0


-26,0


-25,4

Net income
Million USD
Released
Forecast
Spread
-107
-64,9
-64.9%
-79,1
-74,7
-5.82%
-108
-69,2
-56.88%
-37,8
-71,8
47.4%
-54,5
-41,7
-30.49%
-40,6
-36,7
-10.64%
-35,5
-38,1
6.64%
-33,9
-34,3
1.19%
-25,0
-26,1
4.14%

-24,3


-23,7


-24,2


-23,8

EPS
USD
Released
Forecast
Spread
-6,00
-3,83
-56.79%
-4,32
-4,12
-4.86%
-5,52
-3,74
-47.59%
-1,80
-3,55
49.27%
-2,64
-2,02
-30.95%
-1,92
-1,74
-10.34%
-1,56
-1,74
10.34%
-1,56
-1,52
-2.63%
-5,67
-1,24
-356.34%

-1,00


-0,96


-0,96


-0,93

Announcement Date01/03/2210/05/2209/08/2208/11/2201/03/2310/05/2309/08/2309/11/2306/03/24----
  1. Stock Market
  2. Equities
  3. INO Stock
  4. Stock
  5. Calendar Inovio Pharmaceuticals Inc